Your browser doesn't support javascript.
loading
Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study).
Satake, Hironaga; Kato, Takeshi; Oba, Koji; Kotaka, Masahito; Kagawa, Yoshinori; Yasui, Hisateru; Nakamura, Masato; Watanabe, Takanori; Matsumoto, Toshihiko; Kii, Takayuki; Terazawa, Tetsuji; Makiyama, Akitaka; Takano, Nao; Yokota, Mitsuru; Okita, Yoshihiro; Matoba, Koreatsu; Hasegawa, Hiroko; Tsuji, Akihito; Komatsu, Yoshito; Yoshino, Takayuki; Yamazaki, Kentaro; Mishima, Hideyuki; Oki, Eiji; Nagata, Naoki; Sakamoto, Junichi.
Afiliación
  • Satake H; Cancer Treatment Center, Kansai Medical University Hospital, Osaka, Japan.
  • Kato T; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Oba K; Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Kotaka M; Department of Biostatistics, The University of Tokyo, Tokyo, Japan.
  • Kagawa Y; Department of Gastrointestinal Cancer Center, Sano Hospital, Kobe, Japan.
  • Yasui H; Department of Gastrointestinal Surgery, Kansai Rosai Hospital, Amagasaki, Japan.
  • Nakamura M; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Watanabe T; Department of Chemotherapy, Aizawa Hospital, Matsumoto, Japan.
  • Matsumoto T; Department of Surgery, Himeji Red Cross Hospital, Himeji, Japan.
  • Kii T; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Terazawa T; Department of Medical Oncology, Himeji Red Cross Hospital, Himeji, Japan.
  • Makiyama A; Cancer Chemotherapy Center, Osaka Medical College Hospital, Takatsuki, Japan.
  • Takano N; Cancer Chemotherapy Center, Osaka Medical College Hospital, Takatsuki, Japan.
  • Yokota M; Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu, Japan.
  • Okita Y; Cancer Center, Gifu University Hospital, Gifu, Japan.
  • Matoba K; Department of Surgery, Tokai Central Hospital, Kakamigahara, Japan.
  • Hasegawa H; Department of Surgery, Kurashiki Central Hospital, Kurashiki, Japan.
  • Tsuji A; Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
  • Komatsu Y; Department of Gastrointestinal Medicine, Kobe Rosai Hospital, Kobe, Japan.
  • Yoshino T; Department of Gastroenterology and Hepatology, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Yamazaki K; Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
  • Mishima H; Division of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Japan.
  • Oki E; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Nagata N; Department of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Sakamoto J; Division of Cancer Center, Aichi Medical University, Aichi, Japan.
Oncologist ; 25(12): e1855-e1863, 2020 12.
Article en En | MEDLINE | ID: mdl-32666647
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Trifluridina Límite: Humans Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Trifluridina Límite: Humans Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Japón